SCHEMBL17499010

SCHEMBL17499010

CC=C(NCC)C(=O)OC

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TET2 Q6N021 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 1/20 0.33
TGFBR1 P36897 1/20 0.32
MCL1 Q07820 1/20 0.32
KDM4A O75164 1/20 0.32
EPHX1 P07099 2/20 0.31
FAAH O00519 1/20 0.31
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
HCAR2 Q8TDS4 1/20 0.31
TSHR P16473 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28058398 0.82 TET2 (0.34) TET2EGLN1MMP1MMP2MMP3
SCHEMBL8081528 0.82 EGLN1 (0.44) EGLN1ALDH1A1KMT2ATSHR
SCHEMBL8081526 0.82 EGLN1 (0.44) EGLN1ALDH1A1KMT2ATSHR
SCHEMBL23380868 0.76 ALDH1A1 (0.42) MMP1MMP2MMP3MMP9MMP8
SCHEMBL4291255 0.75
SCHEMBL4222788 0.75
SCHEMBL9835228 0.73 ALDH1A1 (0.39) TET2EGLN1ALDH1A1
SCHEMBL9835217 0.73 ALDH1A1 (0.39) TET2EGLN1ALDH1A1
SCHEMBL10986950 0.72
SCHEMBL10986955 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768502-A1 INK COMPOSITION FOR COSMETIC CONTACT LENSES Johnson & Johnson Vision Care, Inc. (US) 2021-01-27 EP claimed
WO-2019180591-A1 INK COMPOSITION FOR COSMETIC CONTACT LENSES JOHNSON & JOHNSON VISION CARE, INC. (US) 2019-09-26 WO claimed
WO-2016025747-A1 NONLINEAR COPOLYMERS AS INTRACELLULAR DELIVERY VEHICLES AND RELATED METHODS STAYTON PATRICK S (US) 2016-02-18 WO disclosed